CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma
Feifan Yao, Suiqing Zhou, Ruizhi Zhang, Yining Chen, Wei Huang, Kai Yu, Nanmu Yang, Xiangjun Qian, Xiaofeng Tie, Jiali Xu, Yu Zhang, Tasiken Baheti, Jing Xu, Xinzheng Dai, Xiaopei Hao, Liren Zhang, Xuehao Wang, Qing Li, Xuehao Wang, Qing Li
Topics & Concepts
Cancer researchBiologyGene knockdownHepatocellular carcinomaCRISPRCell cultureGeneticsGeneFerroptosis and cancer prognosisRNA modifications and cancerCancer-related molecular mechanisms research